Table 2 Clinical features of subtypes in TCGA_UVM cohort. IQR means interquartile range
| Â | level | Cluster1 | Cluster2 | p | test |
|---|---|---|---|---|---|
n | Â | 38 | 42 | Â | Â |
futime (median [IQR]) | 814.50 [458.75, 1161.25] | 759.50 [433.50, 1204.25] | 9.96E-01 | wilcox Test | |
fustat (median [IQR]) | 0.00 [0.00, 1.00] | 0.00 [0.00, 0.00] | 5.05E-04 | wilcox Test | |
age (median [IQR]) | 60.00 [53.00, 71.75] | 63.50 [51.00, 75.00] | 8.25E-01 | wilcox Test | |
gender (%) | female | 13 (34.2) | 22 (52.4) | 1.58E-01 | Chisq Test |
male | 25 (65.8) | 20 (47.6) | Â | ||
stage (%) | Stage II | 13 (34.2) | 23 (54.8) | 1.75E-01 | Chisq Test |
Stage III | 23 (60.5) | 17 (40.5) | Â | ||
Stage IV | 2 (5.3) | 2 (4.8) | Â | ||
histological_type (%) | epithelioid | 10 (26.3) | 3 (7.1) | 5.60E-03 | Chisq Test |
mixed | 20 (52.6) | 17 (40.5) | Â | ||
spindle | 8 (21.1) | 22 (52.4) | Â | ||
chromosome.3.status (%) | disomy | 14 (36.8) | 24 (57.1) | 1.12E-01 | Chisq Test |
monosomy | 24 (63.2) | 18 (42.9) | Â | ||
MetStatus (%) | Metastatic | 21 (55.3) | 5 (11.9) | 9.79E-05 | Chisq Test |
Non-metastatic | 17 (44.7) | 37 (88.1) | Â | ||
vital_status (%) | alive | 20 (52.6) | 37 (88.1) | 1.14E-03 | Chisq Test |
dead | 18 (47.4) | 5 (11.9) | Â | ||
SCNA_Cluster (%) | A | 4 (10.5) | 11 (26.2) | 7.66E-02 | Chisq Test |
B | 10 (26.3) | 13 (31.0) | Â | ||
C | 10 (26.3) | 12 (28.6) | Â | ||
D | 14 (36.8) | 6 (14.3) | Â | ||